primary liver cancer
Conditions
Interventions
Treatment group:Wear a nasal mask device containing a nasal inhalation prescription and administer the drug through the nasal mucosa by nasal inhalation and mouth exhalation
Control group:Herbal decoction treatment
Sponsors
Institute of Chinese Medical History Documents, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) The subject voluntarily participates and signs the informed consent form; (2) Age= 18 years old; (3) Patients diagnosed with primary liver cancer, CNLC is stage I. or II, and is not suitable for surgery and ablation treatment.
Exclusion criteria
Exclusion criteria: (1) Patients with ascites and portal hypertension; (2) pregnant or lactating women; (3) Patients with mental and psychological diseases such as cognitive or psychiatric disorders; Serious diseases of other organs such as tumors, blood diseases, heart diseases, etc.; (4) Those who are allergic to sniffing drugs; (5) Patients with dry rhinitis or sinusitis and other uncomfortable diseases caused by inhalation; (6) Participating in other clinical trials at the same time or other circumstances judged by the investigator to be inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Scale for Patients with Liver Cancer;Alpha fetoprotein;Body weight measurement value;Adverse reaction; | — |
Countries
China
Contacts
Public ContactJianfeng Liu
Institute of Chinese Medical History Documents, China Academy of Chinese Medical Sciences
Outcome results
None listed